Clinical Trial Update: Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, pharmacodynamics, safety and tolerability of oral BL-7040 in moderately active ulcerative colitis. Results completed and post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BL-7040

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2014-05-01